Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
‘A shot of adrenaline’ : readers pass on 90s club classics to new generations
5/11/2025
Propagate, repot, swap : how to fill your home with houseplants on a budget
5/11/2025
Autumn in Alentejo : ancient city sites and golden vineyards in Portugal
5/11/2025
Wings by Paul McCartney review – a brilliant story of post-Beatles revival
5/11/2025
A moment that changed me : I thought I was a lesbian. David Bowie made me realise the truth
5/11/2025
Mirepoix kimchi and vegetarian umami chilli : Kenji Morimoto’s recipes for cooking with homemade ferments
5/11/2025